LIVN - LivaNova PLC
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $0.80
|
Rev Est: $354.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$74.33
DETAILS
HIGH:
$85.00
LOW:
$66.00
MEDIAN:
$73.50
CONSENSUS:
$74.33
UPSIDE:
7.65%
Market Cap:
3.77B
Volume:
1,668,160
Avg Volume:
730,694
52 Week Range:
32.48-69.52
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.94
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
GB
Employees:
2,900
IPO Date:
2015-10-19
EPS (TTM):
1.17
P/E Ratio:
39.72
Revenue (TTM):
1.25B
Total Assets:
2.51B
Total Debt:
676.77M
Cash & Equiv:
428.86M
Rev Growth (5Y):
2.9%
EPS Growth (5Y):
-6.3%
FCF Growth (5Y):
6.6%
ROCE:
7.2%
Debt/Equity:
0.51
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $1.11 | $0.92 | +20.8% | $357.8M | $342.7M | +4.4% |
| 2025-08-06 | $1.05 | $0.84 | +25.0% | $352.5M | $342.1M | +3.0% |
| 2025-05-07 | $0.88 | $0.75 | +17.3% | $316.9M | $330.9M | -4.2% |
| 2025-02-25 | $0.81 | $0.80 | +1.3% | $321.8M | $308.7M | +4.3% |
| 2024-10-30 | $0.90 | $0.71 | +26.8% | $318.1M | $323.6M | -1.7% |
| 2024-07-31 | $0.93 | $0.79 | +17.7% | $318.6M | $304.2M | +4.7% |
| 2024-05-01 | $0.73 | $0.45 | +62.2% | $294.9M | $304.2M | -3.1% |
| 2024-02-21 | $0.87 | $0.79 | +10.1% | $310.1M | $287.4M | +7.9% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.25B | 1.15B | 1.02B | 1.04B | 934.24M | 1.08B | 1.11B | 1.01B | 1.21B | 291.56M | 282.01M | 254.32M |
| Net Income | 63.23M | 17.55M | (86.25M) | (135.82M) | (348.82M) | (157.64M) | (189.40M) | (25.10M) | (62.80M) | 57.85M | 54.89M | 46.36M |
| EPS | 1.17 | 0.33 | -1.61 | -2.68 | -7.06 | -3.22 | -3.91 | -0.52 | -1.29 | 2.19 | 2.02 | 1.68 |
| Total Assets | 2.51B | 2.43B | 2.29B | 2.20B | 2.40B | 2.41B | 2.55B | 2.50B | 2.34B | 2.56B | 294.19M | 264.04M |
| Total Debt | 676.77M | 640.40M | 580.43M | 286.70M | 709.14M | 394.86M | 168.30M | 146.00M | 122.90M | 176.82M | 0 | 0 |
| Cash & Equivalents | 428.86M | 266.50M | 214.17M | 207.99M | 252.83M | 61.14M | 47.20M | 93.60M | 39.80M | 112.61M | 103.30M | 120.71M |
| Operating Cash Flow | 183.04M | 74.91M | 69.90M | 102.54M | (79.40M) | (91.14M) | 120.50M | 91.30M | 90.20M | 79.68M | 54.20M | 79.05M |
| Free Cash Flow | 135.93M | 39.93M | 43.40M | 77.07M | (114.40M) | (115.83M) | 82.50M | 57.20M | 53.00M | 72.99M | 35.13M | 64.75M |
| FCF per Share | 2.51 | 0.74 | 0.81 | 1.52 | -2.35 | -2.40 | 1.70 | 1.19 | 1.08 | 2.77 | 1.29 | 2.35 |
| Book Value | 1.32B | 1.28B | 1.21B | 1.29B | 1.11B | 1.38B | 1.50B | 1.82B | 1.71B | 1.81B | 259.10M | 229.57M |
| Cash & ST Investments | 428.86M | 266.50M | 214.17M | 207.99M | 252.83M | 61.14M | 47.20M | 93.60M | 39.80M | 119.61M | 128.33M | 135.81M |
| ROC Equity | 0.05 | 0.01 | -0.07 | -0.10 | -0.31 | -0.11 | -0.13 | -0.01 | -0.04 | 0.03 | 0.21 | 0.20 |